Alix Earle is adding another brand to her expanding investment portfolio.
The 25-year-old influencer and soon-to-be reality TV star has taken a stake in liposomal supplement brand Cymbiotika, which has been on a cultural hot streak of late and reached $150 million in 2025 revenue.
The investment amount was not disclosed, but Earle joins a number of other celebrity investors in the brand such as Kendall Jenner, Hailey Bieber, Zac Efron, Steve Aoki, Peggy Gou and more.
“[Earle] is honest about what her routine looks like day to day, and now she’s an investor helping to shape where we go next. To me, she’s where wellness is going: personal, practical and built on things that genuinely work,” said Durana Elmi, cofounder, chief creative officer and chief experiential officer at Cymbiotika in a statement.
Cymbiotika’s liposomal supplements.
Courtesy
Founded in San Diego in 2019, Cymbiotika is known for its signature liposomal format, where supplements come in flavored, single-serving 5-ml. liquid packs. Prices range from $48 for a one-month supply of the Liposomal Elderberry supplement, which aims to prevent flu and cold symptoms, to $88 for the Liposomal Glutathione and Colostrum supplements, respectively.
Other top sellers include vitamin C, NAD+, Magnesium and Sea Moss offerings.
“Between travel, filming and everything else I’ve got going on, I need a supplement that’s convenient to take and actually works,” Earle said in a statement. “I’ve been using [Cymbiotika’s] Glutathione, Colostrum and vitamin C for years, because they’re the only supplements that have actually kept up with my schedule.”
In addition to launching a beauty brand of her own, Reale Actives, in March, Earle has taken several prominent equity deals in recent years.
She invested in Poppi prior to the prebiotic soda brand’s nearly $2 billion acquisition by PepsiCo in 2025, and last year she took stakes in canned margarita brand, SipMargs, and clean energy drink brand, Gorgie.
For Cymbiotika, this deal comes on the heels of several big moves: the brand entered Target last fall; closed a $25 million funding round in January with participation from The Weeknd and Post Malone, among others, and entered Ulta Beauty in March.
“While the Cymbiotika DTC [direct-to-consumer] loyalist remains the ultimate goal — and the brand’s central hub for education, personalization, and full wellness protocols — the past year has been focused on building a true omnichannel experience that meets consumers wherever they are in their wellness journey,” Elmi said. “In the case of Alix Earle, Cymbiotika sees a unique cultural catalyst who can drive awareness and education that naturally translates across every channel.”
